Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second‐line palliative chemotherapy-Reference-Cited by-同舟云学术

Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second‐line palliative chemotherapy

Published:2019-11-28 Issue:10 Volume:35 Page:1694-1703
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Hsu Chih‐Chung¹,Liu Keng‐Hao²,Chang Pei‐Hung³,Chen Ping‐Tsung⁴,Hung Chia‐Yen¹⁵,Hsueh Shun‐Wen³,Yeh Kun‐Yun³,Chen Yen‐Yang⁶,Lu Chang‐Hsien⁴,Hung Yu‐Shin¹,Chou Wen‐Chi¹^ORCID

Affiliation:

1. Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine Chang Gung University Taoyuan Taiwan

2. Department of Surgery, Chang Gung Memorial Hospital at Linkou and College of Medicine Chang Gung University Taoyuan Taiwan

3. Department of Oncology Chang Gung Memorial Hospital at Keelung Keelung Taiwan

4. Department of Oncology Chang Gung Memorial Hospital at Chiayi Chiayi Taiwan

5. Division of Hema‐oncology, Department of Internal Medicine Mackay Memorial Hospital Taipei Taiwan

6. Department of Oncology Chang Gung Memorial Hospital at Kaohsiung Kaohsiung Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14926

Reference36 articles.

1. Cancer statistics, 2017

2. Pancreatic Adenocarcinoma

3. Resection versus other treatments for locally advanced pancreatic cancer;Gurusamy KS;Cochrane Database Syst. Rev.,2014

4. Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

5. Chemotherapy and radiotherapy for advanced pancreatic cancer;Chin V;Cochrane Database Syst. Rev.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab‐paclitaxel plus gemcitabine as second or later‐line treatment;Cancer Medicine;2024-06

2. Development and validation of a novel nutrition-based nomogram to predict prognosis in pancreatic cancer patients receiving first-line systemic chemotherapy from three centres.;2023-10-30

3. Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study;International Journal of Clinical Oncology;2023-05-20

4. A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer;Journal of Clinical Medicine;2023-05-15

5. Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer;Cancers;2023-02-05